HEOR News
Chilean Health Ministry Is Urged to Issue a Compulsory License for the Pfizer COVID-19 Pill (Pharmalot)
Innovarte Corporacion, a nongovernmental organization, and the Chilean Association of Pharmaceutical Chemists and Biochemists are seeking to make it possible for generic manufacturers to sell versions of Pfizer’s COVID-19 medicine, paxlovid, in Chile. Read more.
White House Seeks Out Community Digital Health Examples (pharmaphorum)
The White House Office of Science and Technology Policy is seeking information about ways to deploy digital health technologies effectively in community settings, particularly looking at community-based programs in populations that are currently underserved by healthcare. Read more.
Which Countries Are on Track to Reach Global COVID-19 Vaccination Targets? (Our World in Data)
As the World Health Organization sets a goal that every country will have fully vaccinated at least 70% of its population by mid-2022, the United States, many countries in Africa, and others are not on track to achieve this standard, according to recent data. Read more.
Hospital Lawsuits Over Unpaid Bills Increased By 37% in Wisconsin From 2001 to 2018 (Health Affairs)
Wisconsin court records from the period 2001–2018 show that lawsuits to recover patients’ unpaid medical bills increased 37% during this period, from 1.12 per 1000 residents in 2001 to 1.53 per 1000 residents in 2018, with lawsuits being disproportionately directed at Black patients and patients living in poorer and less densely populated counties. Read more.
Germany Extends Test Phase for ePrescriptions (mobihealth news)
The launch of the country’s mandate for digital prescriptions, scheduled for the beginning of January, has been postponed at the direction of the German Federal Ministry of Health because the necessary technical systems are not yet available across the board. Read more.
Pragmatic Clinical Trials—Ready for Prime Time?
(JAMA Network Open)
Pragmatic trials, conducted in everyday clinical settings, could overcome some of the limitations of traditional trials. Read more.
A New Paradigm Is Needed: Top Experts Question the Value of Advance Care Planning (Kaiser Health News)
A group of prominent experts is saying efforts to get people to specify their end-of-life wishes before becoming terminally ill—including living wills, do-not-resuscitate orders, and other written materials expressing treatment preferences—should stop because they haven’t improved end-of-life care.
Read more.
France Says 110,000 Fake Health Passes in Circulation (France 24)
Some 110,000 fake health passes showing proof of vaccination against COVID-19 are in circulation in France according to the interior ministry, with hundreds of investigations launched against makers and users of the forged documents. Read more.
How Much Longer Can China Keep Up Its Zero-COVID-19 Strategy? (The Guardian)
While the rest of the world is learning to live with COVID-19, in China authorities are doubling down on their “zero-COVID-19” policy, trying to stamp out the disease whenever it appears and at any cost. Read more.
The Role of NITAGs and HTA Agencies in Decision Making for Vaccines (PRMA Consulting)
Marie Chivers, Senior Consultant, looks at the role of national immunization technical advisory groups (NITAGs) as critical stakeholders in decision making for vaccines and considers the varying role of health technology assessment (HTA) agencies in the vaccine appraisal process. Read more.
